Читать книгу Medicina basada en la evidencia y análisis de diseños de investigación clínica - Gilberto Vizcaíno Salazar - Страница 25
Referencias bibliográficas
Оглавление1. Vizcaíno Salazar G. Medicina basada en la evidencia y análisis de diseños de investigación clínica. Maracaibo: Editorial Ediluz; 2002. p. 93.
2. Moodle. INASP. Course Research Writing in Sciences. Disponible en https://moodle.inasp.info/pluginfile.php/166055/mod_resource/content/1/1a._Accessing_research_publications/index.html.
3. Center for Evidence-Based Medicine. Resources. Finding the Evidence 1 – Using PICO to formulate a search question. Disponible www.cebm.net
4. Claro JC, Lustig N, Soto M, Rada G. Medicina basada en evidencia. El primer paso: la pregunta clínica. Rev Med Chile. 2012; 140: 1067-1072.
5. Lozano JM, Dennis RJ. Búsqueda eficiente de literatura biomédica en gastroenterología. La pregunta previa a la búsqueda. Rev Colomb Gastroenterol. 2004; 19: 55-58.
6. Shechter M. Does magnesium have a role in the treatment of patients with coronary artery disease? Am J Cardiovasc Drugs. 2003; 3(4): 231-9.
7. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators (CARE). N Engl J Med. 1996; 335(14): 1001-9.
8. Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998; 339(19): 1349-57.
9. The Scandinavian Simvastatin Survival Study (4S). Randomised trial of cholesterol lowering in 4.444 patients with coronary heart disease. Lancet. 1994; 19,344(8934): 1383-9.
10. Smith AD, Refsum H, Bottiglieri T, Fenech M, Hooshmand B, McCaddon A, Miller JW, Rosenberg IH, Obeid R. Homocysteine and Dementia: An International Consensus Statement. Journal of Alzheimer’s Disease. 2018; 62: 561-570. doi 10.3233/JAD-171042.
11. Durga J, Van Boxtel MP, Schouten EG, Kok FJ, Jolles J et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet. 2007; 369: 208-16.
12. Smith AD, Smith SM, De Jager CA, Whitbread P, Johnston C et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS ONE. 2010; 5: e12244.
13. De Jager CA, Oulhaj A, Jacoby R, Refsum H, Smith AD. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int. J. Geriatr. Psychiatry. 2012; 27: 592-600.
14. Komocsi A, Vorobcsuk A, Kehl D, Aradi D. Use of new-generation oral anticoagulant agents in patients receiving antiplatelet therapy after an acute coronary syndrome: systematic review and meta-analysis of randomised controlled trials. Arch Intern Med. 2012; 172(20): 1537-154. doi 10.1001/archinternmed.2012.4026.
15. Elsevier Ltd. [Internet]. [Consultado 5 septiembre 2019]. Disponible en: https://www.sciencedirect.com/science/article/pii/S0140673615610947?via%3Dihub